 11-Feb-2015 18:01:24   ; EEGHUB_E_150_700_F_05_30_onepasszerophase_firws_A_80_013_33ms_cue ; Suj4 ; All trials: 799/800;  SupraAlternative_AT: 18/18; SupraFace_FT: 14/14; SubliAlternative_AT: 60/60; SupraFace_AT: 26/26; SubliFace_AT: 60/60; SupraFiller_AT: 96/96; SubliControl_AT: 60/60; SubliBlank_AT: 60/60; SupraControl_AT: 20/20; SupraAlternative_FT: 22/22; SubliControl_FT: 60/60; SubliFace_FT: 60/60; SubliAlternative_FT: 60/60; SupraControl_FT: 20/20; SubliBlank_FT: 60/60; SupraFiller_FT: 103/104;  0 rejected channels   
  11-Feb-2015 18:02:16   ; EEGHUB_E_150_700_F_05_30_onepasszerophase_firws_A_80_013_33ms_cue ; Suj4 ; All trials: 799/800;  SupraAlternative_AT: 18/18; SupraFace_FT: 14/14; SubliAlternative_AT: 60/60; SupraFace_AT: 26/26; SubliFace_AT: 60/60; SupraFiller_AT: 96/96; SubliControl_AT: 60/60; SubliBlank_AT: 60/60; SupraControl_AT: 20/20; SupraAlternative_FT: 22/22; SubliControl_FT: 60/60; SubliFace_FT: 60/60; SubliAlternative_FT: 60/60; SupraControl_FT: 20/20; SubliBlank_FT: 60/60; SupraFiller_FT: 103/104;  0 rejected channels   
  11-Feb-2015 18:03:49   ; EEGHUB_E_150_700_F_05_30_onepasszerophase_firws_A_80_013_33ms_cue ; Suj4 ; All trials: 799/800;  SupraAlternative_AT: 18/18; SupraFace_FT: 14/14; SubliAlternative_AT: 60/60; SupraFace_AT: 26/26; SubliFace_AT: 60/60; SupraFiller_AT: 96/96; SubliControl_AT: 60/60; SubliBlank_AT: 60/60; SupraControl_AT: 20/20; SupraAlternative_FT: 22/22; SubliControl_FT: 60/60; SubliFace_FT: 60/60; SubliAlternative_FT: 60/60; SupraControl_FT: 20/20; SubliBlank_FT: 60/60; SupraFiller_FT: 103/104;  0 rejected channels   
  11-Feb-2015 18:05:14   ; EEGHUB_E_150_700_F_05_30_onepasszerophase_firws_A_80_013_33ms_cue ; Suj6 ; All trials: 795/800;  SupraControl_AT: 19/19; SupraFace_AT: 21/21; SupraAlternative_AT: 21/21; SubliBlank_AT: 59/60; SupraFiller_AT: 98/99; SubliFace_AT: 59/60; SubliAlternative_AT: 60/60; SubliControl_AT: 59/60; SupraControl_FT: 21/21; SupraAlternative_FT: 19/19; SupraFiller_FT: 101/101; SubliBlank_FT: 60/60; SupraFace_FT: 19/19; SubliAlternative_FT: 60/60; SubliFace_FT: 59/60; SubliControl_FT: 60/60;  0 rejected channels   
  11-Feb-2015 18:07:59   ; EEGHUB_E_150_700_F_05_30_onepasszerophase_firws_A_80_013_33ms_cue ; Suj7 ; All trials: 799/800;  SupraFace_AT: 16/16; SupraAlternative_AT: 28/28; SupraAlternative_FT: 12/12; SubliAlternative_AT: 60/60; SubliControl_AT: 60/60; SubliBlank_AT: 60/60; SubliFace_AT: 59/60; SupraControl_AT: 18/18; SupraFiller_AT: 98/98; SupraControl_FT: 22/22; SubliFace_FT: 60/60; SubliAlternative_FT: 60/60; SupraFiller_FT: 102/102; SubliControl_FT: 60/60; SubliBlank_FT: 60/60; SupraFace_FT: 24/24;  0 rejected channels   
 